Rating History for Gilead Sciences (GILD) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/4/2021 | Whitney Ljem | Upgrade | Buy (Neutral) |
N/A (N/A) |
58.26 (146.12) |
150.81% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/4/2021 | Whitney Ljem | Upgrade | Buy (Neutral) |
N/A (N/A) |
58.26 (146.12) |
150.81% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||